GEN
Nadir Ulu, MD, PhD, currently serves as Vice President of R&D and Clinical Operations at Gen since July 2019, following a tenure as Vice President of R&D and Manufacturing. Prior experience includes multiple roles at Celgene from February 2013 to July 2019, culminating in the position of Medical Director. Nadir Ulu's career began at Gen as a Medical Manager from October 2011 to February 2013, preceded by a Postdoctoral position at Ankara University Faculty of Medicine in Pharmacology and Clinical Pharmacology. Academic credentials include a PhD in Clinical Pharmacology from the University of Groningen and an MD from Hacettepe University. Initial professional experience involved a role as a Doctor at the Republic of Turkey Ministry of Health.
This person is not in any offices
GEN
4 followers
Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. joined Turkish pharmaceutical market in 1998, supplies products used in treatment of rare diseases and disorders in Neurology, Endocrinology, Nephrology, Oncology, Hematology and Pediatric branches. Teamed up with its leading international partners and compliant with ethical and scientific principals, Gen aims to bring these products to patients in the easiest, fastest and most reliable way possible. With its fast and steady growth during this 20 years, Gen became the fastest growing pharmaceutical company in Turkey with its GMP certificated production facility based in Ankara, offices in Ankara (HQ), İstanbul, İzmir, Trabzon, Azerbaijan, Kazakhstan and Georgia, 400 employees and 17 partners from 15 different countries.